10-Q quarterly report · filed Nov 3, 2026

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) Q3 2026 10-Q Quarterly Report

Short answer

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $65M (up 0.4% year over year) with net income of $32M.

Q3 2026 key financials · XBRL

Revenue
$65M
+0.4% YoY · +2.5% QoQ
Net income
$32M
+8.8% YoY · −27.3% QoQ
Operating margin
45.3%
EPS (diluted)
$0.99
+2.1% YoY · −27.7% QoQ

Source: XBRL data from the INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) Q3 2026 10-Q on SEC EDGAR. USD.

INNOVATIVE INDUSTRIAL PROPERTIES INC Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $64.9M, up 0.4% YoY from $64.7M, driven by rent escalations, re-leasing and security-deposit applications
  • Net income $31.9M vs $29.3M YoY, net margin 49.1% vs 45.3%
  • Best segment: Life Science, $10.4M quarterly net income vs insignificant prior-year income
  • Operating cash flow $150.4M for nine months, up from $148.3M; ending cash and restricted cash $145.3M
  • Cannabis headwinds: tenant defaults, pricing pressure, constrained capital and uncertainty around DEA rescheduling implementation

Risk Factors

  • Newly added IQHQ investment risk: $411.0 million exposure represented 16% of total assets as of September 30, 2026
  • Most material update: approximately $134.0 million IQHQ Alewife commitment remained unfunded, with advance timing outside IIP’s control
  • Regulatory risk: IRS challenge to Alewife loan’s REIT treatment could jeopardize REIT qualification
  • Operational risk: IQHQ borrower deterioration could impair repayment across multiple investments simultaneously
  • Financial risk: IQHQ investments secure the IIP Life Science Credit Facility, potentially restricting liquidity and borrowing capacity

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other INNOVATIVE INDUSTRIAL PROPERTIES INC quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.